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OBJECTIVE: The objective of this selective EBM review is to determine whether or not “Are 
PRP and HA injections beneficial for symptomatic relief when administered as combination 
therapy in patients with knee osteoarthritis?” 
 
STUDY DESIGN: A systematic review of two randomized control trials (RCTs) and one case 
series published between 2016-2018.   
 
DATA SOURCES: Sources were found using PubMed and Cochrane. Sources were selected 
based on patient-oriented evidence of therapeutic effects from HA and PRP injections as 
monotherapy and combination therapy in symptomatic relief for patients with knee osteoarthritis.  
 
OUTCOMES MEASURED: Patient-reported pain score was recorded after treatment using 
Visual Analog Scale (VAS) or Western Ontario and McMaster Universities Osteoarthritis 
(WOMAC) Index. One RCT used WOMAC; the other RCT and the case series used VAS.  
 
RESULTS: One RCT (Lana JF, Weglein A, Sampson SE, et. al Randomized controlled trial 
comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of 
mild and moderate osteoarthritis of the knee. J Stem Cells Regen Med. 2016;12(2):69–78. 
Published 2016 Nov 29.) showed a significant improvement in VAS pain score when patients 
were treated with combination therapy vs monotherapy by HA (p=<0.05). Another RCT (Yu W, 
Xu P, Huang G, Liu L. Clinical therapy of hyaluronic acid combined with platelet-rich plasma 
for the treatment of knee osteoarthritis. Exp Ther Med. 2018;16(3):2119–2125.) showed that 
combination therapy also provided significant improvement (p=<0.05) in pain when patients 
reported using the WOMAC index. The case series also showed improved VAS scores before 
and after combination treatment (Chen SH, Kuan TS, Kao MJ, Wu WT, Chou LW. Clinical 
effectiveness in severe knee osteoarthritis after intra-articular platelet-rich plasma therapy in 
association with hyaluronic acid injection: three case reports. Clin Interv Aging. 2016;11:1213–
1219. Published 2016 Sep 8. doi:10.2147/CIA.S114795). 
 
CONCLUSION:  The studies that were used in this systematic review conclude that 
combination of PRP and HA provide significantly improved results in pain when using either 
VAS or WOMAC indexes to assess pain before and after treatment. Future studies should 
consider radiographic imaging before and after treatment to produce objective results. Also, 
bigger sample sizes and monitoring short and long-term effects of combination therapy during 
trials would be beneficial since combination of HA and PRP is relatively novel.  
 












Knee osteoarthritis (OA) is a chronic degenerative joint disease due to loss of cartilage 
over time leading to joint space narrowing between the femur and tibia. The loss of cartilage and 
synovial fluid in the joint leads to increased bone-on-bone contact which results in decreased 
range of motion, inflammation, stiffness, and pain in the knee joint.1 The significance of articular 
cartilage is that it acts as a buffer in order to provide flexibility and full range of motion to the 
knee.2 It is composed of a dense extracellular matrix which is composed of proteoglycans, 
hyaluronic acid, and link protein.2 The degenerative loss of this material in the knee joint leads to 
osteoarthritis. Mostly affecting the middle to elderly aged population, some risk factors of knee 
osteoarthritis are obesity, prior trauma to the joint, overuse of the joint, genetics, etc.1  
Knee osteoarthritis is a common condition in the United States affecting 10% of men and 
13% of women over age 60.3 The increasing number of Americans affected with knee 
osteoarthritis has contributed to more than $41 billion annually in health care with an average 
lifetime cost being between $12,400 and $16,000 per patient.6 In 2013, there were 20.78 million 
knee OA-related ambulatory visits and 2.95 million inpatient visits.6 Due to the increasing 
prevalence and noncomplex initial treatment, osteoarthritis is commonly treated in primary care 
facilities, making it well within the scope of practice for physician assistants.4 Initial stages of 
mild to moderate osteoarthritis are served with non-costly conservative treatment such as 
nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen.5 However, costs rise in 
treating osteoarthritis when patients fail conservative measures and/or carry multiple 
comorbidities. These patients eventually require invasive procedures such as intra-articular 
analgesia and eventual total knee replacements. In order to lower cost while providing higher 
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quality care by prolonging the time period before knee transplant, novel forms of treatment such 
as intra-articular injections of hyaluronic acid and platelet-rich plasma are being researched and 
gradually implemented in orthopedic practices across the country.  
Current forms of treatment for arthritis such as acetaminophen, NSAIDs, and 
intraarticular corticosteroids provide temporary symptomatic relief by lessening joint 
inflammation and pain and overall improve stiffness. The gradual degeneration of the joint and 
cartilage is however irreversible. Conservative measures such as weight loss may decrease the 
pressure on joints and help delay progression of arthritis. However, understanding that knee 
cartilage is the foundation of the joint, research on treatment that promotes cartilage healing is 
being conducted.7 Furthermore, studies have shown symptomatic relief from hyaluronic acid 
(HA) and platelet-rich plasma (PRP) injections.7  
Hyaluronate occurs naturally in the joint cartilage and synovial fluid composed of N-
acetyl-d-glucosamine and d-glucuronic acid residues.8 When knee OA progresses and 
hyaluronate is depolymerized, exogenous hyaluronic acid can be injected into the joint to allow 
lubrication and opening of the joint.8 On the other hand, PRP is a plasma mixture containing five 
times more platelets than in human blood.9 Evidence suggests that this allows PRP to provide 
regenerative effects and hemostasis to the knee joint.9 Studies exist which evaluate the 
effectiveness of symptomatic improvement from HA and PRP injections as monotherapy. What 
is unknown however, is the symptomatic benefits of combining HA and PRP in intra-articular 
administration.7 Considering both products have different mechanisms of action, combination of 








 The objective of this selective EBM review is to determine whether or not PRP and HA 
injections are beneficial in symptomatic improvement for knee osteoarthritis patients when 
administered as combination therapy.  
METHODS 
 Two randomized controlled trials and one case series were used in this review. The 
population studied was patients with symptomatic knee osteoarthritis. The intervention in all 
three studies was combination of HA and PRP therapy. The comparison was HA and PRP 
monotherapy which was discussed in the two RCTs, not in the case series. This review will focus 
on effects of HA and PRP combination compared to HA monotherapy. Some tools used to report 
pain were Visual Analog Scale (VAS) and Western Ontario and McMaster Universities Arthritis 
Index (WOMAC).5 Using VAS to report pain makes the outcomes subjective to the patient, 
therefore it is patient-oriented data. Another tool to report painted oriented outcomes is 
WOMAC, a questionnaire asking osteoarthritis patients to report level of difficulty with daily 
tasks. The answers on the WOMAC questionnaire help data collectors to develop a total score 
between 0-20 for pain, 0-8 for stiffness, and 0-68 for functional disability.2 The RCT by Lana et. 
al and case series by Chen et. al used VAS to report knee pain in patients. However the RCT by 
Yu et. al used the WOMAC index to report pain.  
 All studies in this review are in English, were published in peer-reviewed journals, and 
found on PubMed and Cochrane libraries. Keywords used to find them were “PRP”, “HA”, 
“combination”, and “osteoarthritis.” The inclusion criteria for this review were subjects with 
symptomatic knee osteoarthritis. In addition RCTs, case reports, or case series published in the 
past 5 years were included. Studies excluded were ones older than 5 years and ones that did not 
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report patient-oriented outcomes. The data reported in these studies includes mean changes and 
p-values.  
Table 1- Demographics & Characteristics of Included Studies 
 
Study Type # Pts Age  Inclusion 
Criteria 
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All studies evaluated symptomatic improvement after monotherapy of HA or PRP 
combination therapy. In the Lana et. al study, changes in pain level were reported by patients 
using VAS.5 The HA group received 2.0 mL of high molecular weight non cross-linked 
hyaluronic acid extracted from bacterial cells. The combination received 2.0 mL of HA followed 
by 5 mL of PRP. After administration all patients applied ice-packs for 30 minutes, three times a 
day, for 2 days after injection. Patients were screened at baseline and then monitored for one year 
at four intervals: 1 month, 3 months, 6 months, and 1 year.5 The median change in VAS scores in 
1 year was analyzed in this review.5  
 The Yu et. Al study used the WOMAC scale for patient-reported pain, stiffness, and 
functional limitation changes after treatment.7 A total of 360 patients were divided into groups 
where they received weekly double-blind treatment with HA, PRP, combination of PRP and HA, 
or a placebo.7 The HA group received weekly administration of 0.20 mg of HA and the PRP 
group received weekly administration of 8 mL of PRP for 8 weeks. The WOMAC pain, stiffness, 
and physical function was reported at baseline and at the 52 week post-treatment mark. A change 
in score was analyzed and p-values to assess significance were generated.7  
 The case series by Chen et. Al included three cases of moderate to severe osteoarthritis 
patients where VAS was used to report pain before and after one treatment of combination HA 
and PRP therapy. Each patient was injected with 10 mL of PRP.2 Two types of HA was used: 
two of the patients were injected with 20 mg/2mL of Hyalgan and the other was injected with 








 All studies examined the effects of combination HA and PRP therapy on osteoarthritis 
patients. The two RCTs compared effects of combination therapy vs effects of monotherapy. The 
case series monitored effects of combination PRP and HA therapy with no comparison to 
monotherapy. The Lana et. al RCT included 105 patients who were all overweight per BMI and 
had moderate knee osteoarthritis.5 Majority of the patients had comorbidities such as 
hypothyroidism, dyslipidemia, and hypertension.5 Patients were divided into 3 groups where they 
received either HA (n=36), PRP, (n=36) or HA+PRP therapy (n=33). Patients were assessed at 
baseline, one month, 3 months, 6 months, and 1 year.5 Pain reduction was statistically significant 
in the combination group at all time intervals. Data is shown in table 2.  
Table 2: Lana et. al Mean change in VAS pain score at Baseline and Days Post-treatment5 
 Mean Change in HA Mean change in 
HA+PRP 
P-values HA vs HA+PRP 
Baseline 7.0 7.0 0.1447 
30 days  -3.0 -4.0 0.0113 
90 days -3.0 -6.0 0.0000 
180 days -3.0 -5.0 0.0000 
360 days -2.0 -5.0 0.0000 
 
 In the Yu et. al study, 360 patients were divided into four groups to receive once weekly 
double-blind treatment of the following for 52 weeks: HA (n=88), PRP (n=104), combination 
therapy of HA and PRP (n=96), or a placebo (n=72).7 Patients who were immunocompromised 
or on anti-coagulants were excluded from the study.7 Pain was assessed using the WOMAC 
index at baseline and at 52 weeks.7 The study concluded that combination of PRP and HA 
treatment showed improved WOMAC pain score vs HA or PRP monotherapy.7 Data for this is 
shown in table 3.  
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Table 3: Yu et. al Mean change in WOMAC pain score at Baseline and Days Post-treatment7 
 Mean Pain Score in HA 
Group 
Mean Pain Score in 
HA+PRP Group 
Baseline 8.91 8.94 
52 weeks 5.26 3.32 
Mean Change 3.61 5.58 
P-Value 0.01 <0.0001 
 
 In the Chen et. al case series, 3 patients were evaluated at the China Medical University 
Hospital in 2014.2 Case 1 and case 2 were given weekly PRP+HA combination therapy for 6 
weeks and asked to report pain using VAS before and after treatment.2 Case 3 was given 
combination therapy weekly for a total of 3 weeks and an additional treatment after five months 
due to continued pain. The patients in the study included case 1: a 77-year old female with 
normal BMI and no previous knee trauma who received weekly combination HA and PRP 
therapy for 6 weeks, case 2: a 69-year old overweight female who regularly visited physical 
therapy for gait disturbance and received weekly combination therapy for 6 weeks, and case 3: a 
76-year old female who also regularly sees physical therapy for gait disturbance who received 
weekly combination therapy for 3 weeks.2 Patient case 1 reported an 85 on VAS pain score (0-
100) before treatment and 23 after 6 weeks of treatment, Patient 2 reported 87 before treatment 
and 30 after treatment. Patient 3 reported 81 before treatment and 0 after treatment.2 A mean 
change or p-value was not calculated in this study.  
DISCUSSION 
  Osteoarthritis is a progressive disease resulting in joint cartilage loss, synovitis, and 
subchondral bone remodeling which results in pain and loss of function.2 Long-term treatment of 
knee osteoarthritis is challenging with the goal being to prolong conservative treatment until 
knee replacement is absolutely necessary. With the short life of oral or intraarticular analgesics, 
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intraarticular hyaluronic acid and platelet-rich plasma injections have been considered to prolong 
the time before knee replacement.2 PRP is considered a multifunctional platelet concentrate that 
promotes synovial cell proliferation and cartilage recovery.7 This is a beneficial treatment 
because unlike NSAIDs, PRP therapy attempts to reverse the degenerative processes faced in 
knee osteoarthritis.7 On the other hand, HA therapy has more viscoelastic and lubricant 
properties of the synovial fluid in the knee joint. Injection of this mimics the effects of synovial 
fluid and improves pain and function.7  
The idea that the combination of both of these products could produce an additive effect 
on symptomatic relief in knee osteoarthritis is a relatively novel topic that has been researched in 
very few studies. This review analyzed two RCTS and one case series in order to assess the 
efficacy of combination PRP and HA injections. The Lana et. al RCT showed significant 
improvement in VAS pain scores in patients receiving combination therapy vs HA monotherapy 
at all intervals assessed.5 According to literature, because of the difference in mechanism of 
action of both PRP and HA, it demonstrates better effects in pain improvement.5 The time the 
combination of HA and PRP takes to create an effect on patients is about 30-90 days, which 
explains the greatest change in pain scores between that time.5 One limitation to consider 
however in this RCT is that more patients in the combination treatment group had comorbidities 
such as hypothyroidism and hypertension compared to other groups. Another limitation of this 
study was the absence of imaging to assess the efficacy of combination treatment objectively.5 
MRI would have helped identify improvement in osteoarthritic changes however this was not 
feasible due to cost.5  
The Yu et. al study demonstrated that combination therapy resulted in statistically 
significant improvement in pain however, HA monotherapy produced statistically significant 
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results as well in improvement of WOMAC pain scores.7 Some treatment-adverse effects 
mentioned from HA therapy alone were hypertension and proteinuria.7 An important factor to 
note however, is that out of 360 patients, 25% stopped participation and could not finish all 
phases of treatment due to side effects such as hypertension, constipation, or diarrhea.7 Overall, 
this study concluded that combination of HA and PRP therapy is beneficial in long-term pain 
improvement and additional trials should be conducted.7  
The Chen et. al case series reported the three osteoarthritis patients having pain 
improvement as well as better physical function post combination therapy.2 It also confirmed 
efficacy of combination treatment with knee x-rays before and after treatment which showed 
regeneration of articular cartilage.2 There were quite a few limitations in this study. First, this 
was a case series only containing 3 patient cases. A larger patient population would have 
provided stronger data. In addition, this case series only tested combination therapy of HA and 
PRP.2 There was no control group. In addition, knee X-rays were not all performed standing.2 
Uniformity of having all patients standing would have possibly allowed better measurement of 
articular changes before and after treatment.2 The authors of this study concluded that further 
studies in a randomized setting with a larger patient population and a control groups is 
necessary.2 
CONCLUSION 
The studies examined in this systematic review provide favorable data for efficacy of 
combination treatment of HA and PRP vs HA monotherapy. The Lana et. al RCT showed 
significantly improved pain from combination therapy vs HA therapy alone up to one year after 
treatment.5 In addition, the Yu et. al RCT also concluded that combination of PRP and HA was 
determined to be significantly more beneficial than HA monotherapy when analyzing WOMAC 
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pain scores.7 Although the Chen et. al case series also supported the conclusion that combination 
therapy significantly provided pain relief, it did not have a control group to compare treatment 
effects with. In addition, the case series only included three cases. If there were more patients 
included in the study it would have strengthened the data.  
Further studies should be done that include larger patient population in order to provide 
more accurate data. In addition, further RCTs should consider investigating the effects of PRP 
and HA combination treatment by evaluating radiographic imaging before and after treatment in 
order to make objective conclusions. Also, since combination PRP and HA therapy is relatively 
novel, future trials should also consider monitoring patient safety and note common short-term 
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